Schedule 13D ownership disclosure

PSYENCE BIOMEDICAL LTD

Common Stock, without par value · CUSIP: 74449F308

Event date: 2025-11-25

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • KAOS Capital Ltd.Reported CIK 0002100448

    Shares: 313,876.00 · Class: 16.77%

  • Adam ArvivReported CIK 0002100451

    Shares: 313,876.00 · Class: 16.77%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001539497-25-003250
Form type
SCHEDULE 13D
Filer
Kaos Capital Ltd
CIK
CIK 2100448
Filed
Dec 10, 2025
Reporting period
Nov 25, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub